DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions

Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK
DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions ( Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK )
13 Nov 2013

HPV prevalence in screened population and types associated with cervix disease

Dr Lesley Anderson - Queens University, Belfast, UK
HPV prevalence in screened population and types associated with cervix disease ( Dr Lesley Anderson - Queens University, Belfast, UK )
13 Nov 2013

The DietCompLyf study: Breast cancer survival and phytoestrogen consumption

Dr Ruth Swann - University of Westminster, UK
The DietCompLyf study: Breast cancer survival and phytoestrogen consumption ( Dr Ruth Swann - University of Westminster, UK )
12 Nov 2013

The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer

Dr Daniel Rea - University of Birmingham, UK
The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer ( Dr Daniel Rea - University of Birmingham, UK )
12 Nov 2013

POSH study: Obesity and the outcome of young breast cancer patients

Dr Ellen Copson - University of Southampton, UK
POSH study: Obesity and the outcome of young breast cancer patients ( Dr Ellen Copson - University of Southampton, UK )
12 Nov 2013

PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer

Dr Chris Gallagher - Barts and the London NHS Trust, UK
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer ( Dr Chris Gallagher - Barts and the London NHS Trust, UK )
12 Nov 2013

The role of molecular pathways in therapeutic response and outcomes in breast cancer

Dr Fabrice André - Institut Gustave Roussy, Villejuif, France
The role of molecular pathways in therapeutic response and outcomes in breast cancer ( Dr Fabrice André - Institut Gustave Roussy, Villejuif, France )
8 Nov 2013

Future perspectives: realising the potential of personalised healthcare in gynaecological cancer

Dr Jonathan Ledermann - University College London, United Kingdom
Future perspectives: realising the potential of personalised healthcare in gynaecological cancer ( Dr Jonathan Ledermann - University College London, United Kingdom )
8 Nov 2013

Updates on advances and trials from ASCO; geriatric oncology overview

Dr Supriya Mohile - University of Rochester, New York, USA
Updates on advances and trials from ASCO; geriatric oncology overview ( Dr Supriya Mohile - University of Rochester, New York, USA )
8 Nov 2013

Addressing the challenges of an aging population

Dr Harvey Cohen - Duke University, North Carolina, USA
Addressing the challenges of an aging population ( Dr Harvey Cohen - Duke University, North Carolina, USA )
8 Nov 2013

Adverse effects of treatment on elderly patients

Prof Vesa Kataja - Kuopio University Hospital, Finland
Adverse effects of treatment on elderly patients ( Prof Vesa Kataja - Kuopio University Hospital, Finland )
8 Nov 2013

The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary

Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada
The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary ( Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada )
8 Nov 2013